Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%
View all comments(0)
Hong Kong innovative drug stocks jumped in market trading. HAIXI PHARMA, INNOCARE up 7%; KEYMED BIO-B up 5%; REMEGEN, INNOVENT BIO, SIMCERE PHARMA up 4%; LEPU BIO up 3%.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Japan, South Korea Stocks Under Pressure Again After Rallying; Kospi Falls Nearly 5% as Samsung, SK Hynix Both Drop Over 6% While Kioxia Rises

Palantir (PLTR) Earnings Preview: 8 Straight Beats, 40% Off Its High, Options Price 12% Swing

August Kicks Off: Palantir, AMD, SanDisk Earnings and NFP Jobs Report - 5 Stocks and 3 Macro Events to Watch

Japan, South Korea Stocks Under Renewed Pressure as KOSPI Slumps Over 5%; Samsung, SK Hynix Plunge Nearly 9%

Wall Street Sees SpaceX Revenue Growth Ahead of First Earnings Report; Morgan Stanley Maintains $300 Target





Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.